Page last updated: 2024-08-24

capecitabine and Shock, Cardiogenic

capecitabine has been researched along with Shock, Cardiogenic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Endo, A; Nakashima, R; Takahashi, N; Tanabe, K; Yoshida, Y1
Damianovich, D; Looi, KL; Sidebotham, D; Taylor, GB; To, AC; White, HD1

Reviews

1 review(s) available for capecitabine and Shock, Cardiogenic

ArticleYear
Capecitabine induces both cardiomyopathy and multifocal cerebral leukoencephalopathy.
    International heart journal, 2013, Volume: 54, Issue:6

    Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Capecitabine; Cardiomyopathies; Colorectal Neoplasms; Deoxycytidine; Fluorouracil; Humans; Leukoencephalopathies; Male; Middle Aged; Shock, Cardiogenic

2013

Other Studies

1 other study(ies) available for capecitabine and Shock, Cardiogenic

ArticleYear
A case of cardiogenic shock caused by capecitabine treatment.
    Nature clinical practice. Cardiovascular medicine, 2008, Volume: 5, Issue:11

    Topics: Adenocarcinoma, Mucinous; Antimetabolites, Antineoplastic; Appendiceal Neoplasms; Biomarkers; Biopsy; Capecitabine; Cardiotonic Agents; Chemotherapy, Adjuvant; Coronary Angiography; Deoxycytidine; Echocardiography; Electrocardiography; Female; Fluorouracil; Humans; Middle Aged; Shock, Cardiogenic; Treatment Outcome

2008